Page 120 - Oncology Coder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oncology coder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oncology Coder Today - Breaking & Trending Today

Association Between Low-Income Subsidies and Inequities in Orally Administered Antimyeloma Therapy Use

Medicare Part D low-income subsidies alone are insufficient to improve the uptake and equitable use of high-cost, orally administered antimyeloma therapy. ....

New York , United States , Kyle Cook , Shelleya Jazowski , Ann Pharmacother , Latinx White , Strategic Initiative Of University North Carolina , National Academies , National Academy For State Health , Medicare Payment Advisory Commission , Health Serv Res , School Of Medicine , Department Of Population Health Sciences , Institute For Clinical , J Public Health , University Of North Carolina At Chapel Hill , Information Management Services Ims Inc , Goodrx Health , Lineberger Comprehensive Cancer Center , Vanderbilt Ingram Cancer Center , Institute Of Medicine , Institute Inc , Department Of Medicine , Vanderbilt University School Of Medicine , Agency For Healthcare Research , Leukemia Lymphoma Society ,

'Be courageous and have the gut to invest': 1 oncology leader on collaboration and innovation

Meet William Tse division director of hematology and oncology at MetroHealth in Cleveland. He has a passion for oncology and is focused on collaboration ....

William Tse , Cleveland Based Metrohealth , William Tse , Cellular Immunotherapy , Enome Gene Therapy , Part Cells , Physician Leader ,

2 Minute Medicine Rewind May 15, 2023 | 2 Minute Medicine

Analysis of Body Mass Index in Early and Middle Adulthood and Estimated Risk of Gastrointestinal Cancer 1. Individuals with an overweight or obese BMI are at increased risk for developing colorectal cancer and non-colorectal gastrointestinal cancers. Evidence Rating Level: 2 (Good) Colorectal cancer (CRC) is the 5th most common cancer diagnosed in the United States. ....

United States , Central South University , Rating Level , Cancer Screening Trial , African American , California San Francisco Ovarian Aging Study , Xiangya Hospital , Weekly Rewinds ,

Temporary interruption of endocrine therapy in women with endocrine-responsive breast cancer did not affect cancer outcomes

1. The 3-year incidence of breast cancer in the study group was 8.9% compared to 9.2% in the control group 2. At 3 years follow-up, the distant recurrence in the study group was 4.5% compared to 5.8% in the control group Evidence Rating Level: 1 (Excellent) Study Rundown: The preservation of fertility and the desire ....

Minute Medicine Inc , Rating Level , Breast Cancer Recurrence , Endocrine Therapy , Chronic Disease ,

Trifluridine–Tipiracil and Bevacizumab Improves Survival in Metastatic Pretreated Colorectal Cancer

1. The median overall survival was 10.8 months in the combination group (FTD–TPI + bevacizumab) and 7.5 months in the FTD–TPI alone group, with HR 0.61. 2. The most common adverse events in both groups included neutropenia, nausea, and anemia. Evidence Rating Level: 1 (Excellent) Study Rundown: Trifluridine-tipiracil (cytotoxic nucleic acid analogue) is commonly used ....

Rating Level , Advanced Colorectal Cancer , Tas 102 , Trifluridine Tipiracil , Chronic Disease ,